SRIDHAR VASIREDDY: Open Payments
NPI 1144214966 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,672 in 55 payments from 13 companies in 2025. Trend: 2023 $1,790 · 2024 $1,327 · 2025 $2,672
Food & beverage: $2,672
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 14 | $1,069 |
| Globus Medical, Inc. | 11 | $564 |
| Boston Scientific Corporation | 5 | $266 |
| SI-BONE, INC. | 7 | $175 |
| Amgen Inc. | 1 | $125 |
| SPR Therapeutics, Inc | 1 | $119 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $72 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| MML US, Inc. | 2 | $53 |
Products named: Senza, INTELLIS ADAPTIVESTIM, KYPHON EXPRESS II KYPHOPAK TRAY, Intracept RF Probe, KRYSTEXXA, SPRINT PNS System, SYNCHROMEDII, Intracept.
Industry payments across TX — which companies pay providers there.
